Notch-Induced Myeloid Reprogramming in Spontaneous Pancreatic Ductal Adenocarcinoma by Dual Genetic Targeting

Cancer Research
Phyllis F CheungJens T Siveke

Abstract

Despite advances in our understanding of the genetics of pancreatic ductal adenocarcinoma (PDAC), the efficacy of therapeutic regimens targeting aberrant signaling pathways remains highly limited. Therapeutic strategies are greatly hampered by the extensive desmoplasia that comprises heterogeneous cell populations. Notch signaling is a contentious pathway exerting opposite roles in tumorigenesis depending on cellular context. Advanced model systems are needed to gain more insights into complex signaling in the multilayered tumor microenvironment. In this study, we employed a dual recombinase-based in vivo strategy to modulate Notch signaling specifically in myeloid cells to dissect the tumorigenic role of Notch in PDAC stroma. Pancreas-specific KrasG12D activation and loss of Tp53 was induced using a Pdx1-Flp transgene, whereas Notch signaling was genetically targeted using a myeloid-targeting Lyz2-Cre strain for either activation of Notch2-IC or deletion of Rbpj. Myeloid-specific Notch activation significantly decreased tumor infiltration by protumorigenic M2 macrophages in spontaneous endogenous PDAC, which translated into significant survival benefit. Further characterization revealed upregulated antigen presentation and cyt...Continue Reading

References

Apr 7, 1998·Molecular and Cellular Biology·A BigasL A Milner
Jan 6, 2000·Transgenic Research·B E ClausenI Förster
Dec 6, 2003·Proceedings of the National Academy of Sciences of the United States of America·L Charles MurtaughDouglas A Melton
Nov 8, 2005·Nature Immunology·Andrew M IntlekoferSteven L Reiner
Jan 21, 2006·Cancer Research·Claire E Lewis, Jeffrey W Pollard
Feb 3, 2007·Journal of Cellular Biochemistry·Gerald C ChuRonald A DePinho
Jun 21, 2007·Nature Immunology·Marc Schmidt-Supprian, Klaus Rajewsky
Jul 19, 2008·Development·Hassan NakhaiRoland M Schmid
Jul 22, 2008·The Journal of Surgical Research·Buckminster FarrowDavid H Berger
Jul 25, 2008·Nature·Alberto MantovaniFrances Balkwill
Sep 24, 2008·Proceedings of the National Academy of Sciences of the United States of America·Shawn D BlackburnE John Wherry
May 21, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Joseph F GrossoCharles G Drake
Jul 14, 2010·Proceedings of the National Academy of Sciences of the United States of America·Pawel K MazurJens T Siveke
Sep 8, 2010·Current Topics in Developmental Biology·Ute Koch, Freddy Radtke
Feb 3, 2011·The Journal of Clinical Investigation·Barbara Varnum-FinneyIrwin D Bernstein
Mar 8, 2011·Cell·Douglas Hanahan, Robert A Weinberg
Aug 31, 2012·Cancer Science·Kiyoshi YoshikawaAtsushi Ochiai
Oct 20, 2012·Nature Reviews. Immunology·Susan M Kaech, Weiguo Cui
Jul 23, 2013·Cancer Research·Meritxell GironellaEmma Folch-Puy
Oct 4, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Patrick A OttCaroline Robert
Nov 14, 2013·Cancer Research·Pingyan ChengDmitry Gabrilovich
Jan 1, 2014·OncoTargets and Therapy·Albrecht NeessePatrick Michl
May 6, 2014·Cancer Immunology Research·Ana C Anderson
Jun 9, 2014·Carcinogenesis·Ingunn M StromnesSunil R Hingorani
Jul 25, 2015·Nature Reviews. Immunology·E John Wherry, Makoto Kurachi

❮ Previous
Next ❯

Citations

Oct 1, 2018·Oncology Research and Treatment·Savita Bisht, Georg Feldmann

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Ductal

Ductal carcinoma is a malignant neoplasm involving the ductal systems of any of a number of organs, such as the mammary glands, pancreas, prostate or lacrimal gland. Discover the latest research on ductal carcinoma here.